加入官方line@ 加入FB粉絲團
  • 免費註冊
  • 加入官方line@
  • 加入FB粉絲團

台股 » 個股 » 健亞 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

健亞

(4130)
可現股當沖
  • 股價
    22.35
  • 漲跌
    ▲0.05
  • 漲幅
    +0.22%
  • 成交量
    62張
  • 產業
    上櫃 生技醫療類股

  • 151人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
健亞 (4130)籌碼相關－富邦-新板 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效，來找出真正獲利的贏家所在券商分點，進而追蹤此贏家所操作的股票與軌跡。

股票投資新手教室：一秒知道是否上對大戶列車

富邦-新板 券商分點個股進出

富邦-新板 券商分點全部個股操作績效/獲利分析

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/08/19222.8500.0022.9522160.92%
2024/08/05321.7000.0021.6532211.35%
2024/07/23123.6500.0023.6512130.47%
2024/07/22223.7500.0023.4022140.93%
2024/07/1800.002524.2024.40-25209-11.96%
2024/07/15524.3000.0024.2052062.43%
2024/06/24124.6000.0024.5511920.52%
2024/06/1900.007.624.4424.35-7.6190-4.01%
2024/05/2800.00324.2024.25-3205-1.46%
2024/05/2000.00224.4024.40-2220-0.91%
2024/05/17224.2000.0024.2022190.91%
2024/05/0300.00124.1024.05-1220-0.45%
2024/04/1600.00824.2123.95-8216-3.70%
2024/04/10125.3000.0025.3012130.47%
2024/04/091025.1000.0025.05102134.69%
2024/04/081225.0000.0025.05122115.67%
2024/04/031124.9500.0025.00112105.24%
2024/04/021125.0500.0025.10112135.16%
2024/03/27224.8500.0025.0022240.89%
2024/03/25025.2500.0025.0002250.00%
2024/03/21024.8500.0024.7002300.00%
2024/03/20124.8500.0024.7512300.43%
2024/03/19025.5500.0024.9502310.00%
2024/03/1500.000.125.1025.10-0.1233-0.02%
2024/03/120.125.1500.0025.150.12370.06%
2024/03/110.825.1000.0025.100.82370.35%
2024/03/06125.8500.0025.7512470.40%
2024/03/05026.0000.0025.7502460.00%
2024/03/040.125.9000.0026.000.12510.02%
2024/02/2200.001726.2426.10-17271-6.27%
2024/02/2000.00325.6025.60-3258-1.16%
2024/02/051024.6000.0024.35102543.93%
2024/01/31125.0000.0025.0012570.39%
2024/01/30125.3000.0025.1012640.38%
2024/01/291325.4100.0025.40132684.84%
2024/01/26225.5300.0025.4522770.72%
2024/01/17325.60125.7525.2523300.60%
2023/12/29226.7000.0026.6023420.58%
2023/12/2800.00126.7026.70-1342-0.29%
2023/12/2700.001027.0026.90-10343-2.91%
2023/12/251026.6000.0026.45103342.99%
2023/12/1800.00027.1526.800328-0.01%
2023/12/1500.00026.8026.8503270.00%
2023/12/061027.8100.0027.75103263.06%
2023/12/0400.00128.2528.25-1322-0.31%
2023/11/28127.5500.0027.5013150.32%
2023/11/27228.00428.1527.90-2321-0.62%
2023/11/07127.4500.0027.2013580.28%
2023/10/2400.00125.5025.65-1325-0.31%
2023/10/20125.20125.2525.2003400.00%
2023/10/1800.00325.2525.25-3369-0.81%
2023/09/2500.00126.7526.80-1509-0.20%
2023/09/2100.00126.5526.45-1584-0.17%
2023/09/2000.00226.8026.75-2598-0.33%
2023/09/1100.000.127.2027.25-0.1650-0.01%
2023/09/05427.3500.0027.4046930.58%
2023/09/0400.00127.4027.40-1704-0.14%
2023/09/01227.5500.0027.6027070.28%
2023/08/31328.00127.9527.7527120.28%
2023/08/3000.00127.5027.50-1714-0.14%
2023/08/28427.85227.3327.1527850.25%
2023/08/2500.001227.5628.05-12776-1.54%
2023/08/24426.8000.0026.8047650.52%
2023/08/14425.8000.0025.4541,0770.37%
2023/08/11627.0000.0026.6061,0740.56%
2023/08/10127.5000.0027.0011,0760.09%
2023/08/07427.9500.0027.8541,1290.35%
2023/08/0400.00227.7527.90-21,177-0.17%
2023/07/20128.9000.0028.8011,3810.07%
2023/07/1800.00428.7528.55-41,391-0.29%
2023/07/17229.3300.0029.3021,4120.14%
2023/07/14428.1500.0028.6041,4270.28%
2023/07/0500.002030.8030.85-201,437-1.39%
2023/07/04530.2500.0030.1051,4530.34%
2023/06/30231.3000.0030.3021,4660.14%
2023/06/2900.00530.5030.75-51,427-0.35%
2023/06/1900.00129.4029.30-11,373-0.07%
2023/06/16129.6500.0029.3511,3750.07%
2023/06/121530.3200.0030.20151,3791.09%
2023/06/02231.20230.7330.2001,5250.00%
2023/06/01330.6000.0030.8031,4990.20%
2023/05/2900.001229.6529.85-121,473-0.81%
2023/05/2600.00529.9229.65-51,488-0.34%
2023/05/24131.50431.5131.45-31,446-0.21%
2023/05/23130.75131.4531.3001,4270.00%
2023/05/2200.00930.4730.55-91,368-0.66%
2023/05/19130.00129.7029.7001,3390.00%
2023/05/1800.00128.9029.55-11,307-0.08%
2023/05/0900.00228.9029.85-21,801-0.11%
2023/05/08029.4500.0029.1001,8310.00%
2023/05/05530.3800.0029.8551,8310.27%
2023/05/03130.30030.2029.9011,8150.05%
2023/05/02430.06430.6130.2001,7990.00%
2023/04/28228.53129.3029.3011,7470.06%
2023/04/2600.00126.7526.90-11,748-0.06%
2023/04/2000.00128.5027.95-11,858-0.05%
2023/04/1400.00127.9527.95-12,101-0.05%
2023/04/12127.75227.8827.90-12,262-0.04%
2023/04/1000.00226.8526.85-22,493-0.08%
新藥研發 浩鼎子公司抗癌新藥申請一期臨床 健亞明年完成試驗Anue鉅亨－2022/09/12
...詳全文
健亞轉投資浩宇超音波D針具追蹤系統 獲美台上市許可UDN聯合新聞網－2022/05/09
健亞（4130）今（9）日宣布，轉投資浩宇生醫公司開發的NAVIRFA（納維爾）超音波3D手術針具追蹤系統，雙雙取得美、......詳全文
健亞轉拓資浩宇NaviFUS®產品 首獲研究用途設備訂單UDN聯合新聞網－2021/03/15
健亞（4130）今（15）日宣布，轉投資的浩宇生醫，下半年將取得肝癌治療產品NAVIRFA®之美國510（k）及台灣二類......詳全文
健亞 相關文章